TB-500 (Thymosin β4 Acetate)
BT20
Lyophilized peptide for use under a licensed healthcare provider. Choose single ampule/vial or box of 10. Sourced via Ares Technology Limited (Hong Kong) / Healthtide Biotech manufacturing list dated 7 October 2026. Specification: 20 mg × 10 vials.
- • Prescription / clinician-supervised pathway
- • Same LIRAVEXIN cart and checkout as pen packages
- • Not medical advice — individual suitability is determined by your clinician
Clinical reference (clinician-supervised)
Research interest in wound healing, inflammation modulation, and tissue repair. Clinical evidence for athletic recovery claims is limited; use remains investigational under clinician oversight.
No established FDA-labeled human dosing. Research and clinic anecdotes often cite multi-mg loading then lower weekly amounts—these are not standards of care. Clinician decides.
Not established (anecdotal loading then weekly patterns exist in clinic blogs—do not treat as medical fact).
Typically discussed as subcutaneous or intramuscular in clinic literature.
Typical clinical / literature ranges under clinician supervision — not a prescription and not a DIY dosing guide. Individual dosing is determined solely by the treating clinician.
Liravexin USD for this pack (wholesale comparison · source × 3). Item is added to your shared cart for checkout coordination with your clinician pathway.
Or continue to checkout →